Yttrium Y 90 Resin Microspheres Data Collection in Unresectable Liver Cancer: the RESIN Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel Brown
Vanderbilt University/Ingram Cancer Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
42 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama
Birmingham, Alabama, United States
- University of Arizona Health Sciences
Tucson, Arizona, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Cedars-Sinai Medical Center
Los Angeles, California, United States
- California Pacific Medical Center
San Francisco, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Stanford University
Stanford, California, United States
- University of Colorado, Denver
Denver, Colorado, United States
- Sky Ridge Medical Center
Englewood, Colorado, United States
- Christiana Care Health System
Wilmington, Delaware, United States
- Georgetown University
Washington D.C., District of Columbia, United States
- Baptist Hospital of Miami
Miami, Florida, United States
- University of Miami
Miami, Florida, United States
- Sarasota Memorial Hospital
Sarasota, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Cancer Treatment Centers of America
Atlanta, Georgia, United States
- Emory University
Atlanta, Georgia, United States
- Piedmont Hospital
Atlanta, Georgia, United States
- Advocate Christ Medical Center
Oak Lawn, Illinois, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Ochsner Clinic Foundation
New Orleans, Louisiana, United States
- University of Maryland School of Medicine
Baltimore, Maryland, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Saint Louis University
St Louis, Missouri, United States
- Albany Medical Center
Albany, New York, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Northwell Health- Lenox Hill Hospital
New York, New York, United States
- Carolinas Medical Center
Charlotte, North Carolina, United States
- Wake Forest Medical Center
Winston-Salem, North Carolina, United States
- Cleveland Clinic
Cleveland, Ohio, United States
- University Hospitals Cleveland Medical Center
Cleveland, Ohio, United States
- Oregon Health & Science University
Portland, Oregon, United States
- University of Pennsylvania Cancer Center
Philadelphia, Pennsylvania, United States
- Penn State Health Saint Joseph Medical Center
Reading, Pennsylvania, United States
- Spartanburg Regional Healthcare System
Spartanburg, South Carolina, United States
- Sanford Usd Medical Center
Sioux Falls, South Dakota, United States
- Vanderbilt University/ingram Cancer Center
Nashville, Tennessee, United States
- Methodist Health System
Dallas, Texas, United States
- Houston Methodist Hospital
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Jul 2015
- Primary completion
- 31 Aug 2020
- Completion
- 31 Aug 2021
- Last update posted
- 5 Sept 2021
- Registered enrollment
- 1,653
- Registry id
- NCT02685631
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.